Astragaloside IV alleviates lipopolysaccharide-induced acute kidney injury through down-regulating cytokines, CCR5 and p-ERK, and elevating anti-oxidative ability - Zhou, W; Chen, Y; Zhang, X (Med Sci Monit, 2017)